In silico genetic correlations of multidrug efflux pump gene expression in Staphylococcus aureus

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 222-229

  Kosmidis, Christos ^a   DeMarco, Carmen E ^a   Frempong Manso, Emmanuel ^a   Seo, Susan M ^a   Kaatz, Glenn W ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bioinformatics; Efflux; Multidrug resistance; Quantitative reverse transcription PCR; Regulation; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; DNA TOPOISOMERASE; MDEA PROTEIN; MEMBRANE PROTEIN; MEPA PROTEIN; MESSENGER RNA; MICROORGANISM PROTEIN; MULTIDRUG RESISTANCE EFFLUX PUMP PROTEIN; NORA PROTEIN; NORB PROTEIN; NORC PROTEIN; QACA PROTEIN; QACB PROTEIN; SDRM PROTEIN; SEPA PROTEIN; UNCLASSIFIED DRUG; BACTERIAL DNA;

5' UNTRANSLATED REGION; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; COMPUTER MODEL; CONTROLLED STUDY; ENZYME SPECIFICITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CORRELATION; HALF LIFE TIME; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOT BLOT HYBRIDIZATION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; AMINO ACID SUBSTITUTION; BACTERIAL GENE; BIOLOGY; CHEMICAL STRUCTURE; CONFORMATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MISSENSE MUTATION; MOLECULAR GENETICS; PROCEDURES; RNA STABILITY;

AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; DNA, BACTERIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENES, MDR; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; RNA STABILITY; STAPHYLOCOCCUS AUREUS;

EID: 77954958350     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.05.015     Document Type: Article

References (48)

1. Borges-Walmsley M.I., McKeegan K.S., Walmsley A.R. Structure and function of efflux pumps that confer resistance to drugs. Biochem J 2003, 376:313-338.
2. Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005, 56:20-51.
3. Lomovskaya O., Lee A., Hoshino K., Ishida H., Mistry A., Warren M.S., et al. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999, 43:1340-1346.
4. Markham P.N., Neyfakh A.A. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1996, 40:2673-2674.
5. Brown M.H., Skurray R.A. Staphylococcal multidrug efflux protein QacA. J Mol Microbiol Biotechnol 2001, 3:163-170.
6. Kaatz G.W., Seo S.M., O'Brien L., Wahiduzzaman M., Foster T.J. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob Agents Chemother 2000, 44:1404-1406.
7. Truong-Bolduc Q.C., Zhang X., Hooper D.C. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol 2003, 185:3127-3138.
8. Kaatz G.W., DeMarco C.E., Seo S.M. MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein. Antimicrob Agents Chemother 2006, 50:1276-1281.
9. Kaatz G.W., Thyagarajan R.V., Seo S.M. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob Agents Chemother 2005, 49:161-169.
10. B modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 2002, 184:5457-5467.
11. de Lencastre H., Tomasz A. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1994, 38:2590-2598.
12. Sieradzki K., Tomasz A. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 2003, 185:7103-7110.
13. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997, 40:135-136.
14. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279:593-598.
15. Hiramatsu K., Asada K., Suzuki E., Okonogi K., Yokota T. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett 1992, 298:133-136.
16. Duthie E.S., Lorenz L.L. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 1952, 6:95-107.
17. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 1967, 33:155-166.
18. Holden M.T., Feil E.J., Lindsay J.A., Peacock S.J., Day N.D., Enright M.C., et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004, 101:9786-9791.
19. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
20. Bateman B.T., Donegan N.P., Jarry T.M., Palma M., Cheung A.L. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect Immun 2001, 69:7851-7857.
21. Foster T.J. Molecular genetic analysis of staphylococcal virulence. Methods Microbiol 1998, 27:433-454.
22. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006.
23. Frempong-Manso E., Raygada J.L., DeMarco C.E., Seo S.M., Kaatz G.W. Inability of a reserpine-based screen to identify strains overexpressing efflux pump genes in clinical isolates of Staphylococcus aureus. Int J Antimicrob Agents 2009, 33:360-363.
24. Kaatz G.W., McAleese F., Seo S.M. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 2005, 49:1857-1864.
25. Kaatz G.W., Seo S.M., Ruble C.A. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993, 37:1086-1094.
26. Truong-Bolduc Q.C., Dunman P.M., Strahilevitz J., Projan S.J., Hooper D.C. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 2005, 187:2395-2405.
27. Truong-Bolduc Q.C., Strahilevitz J., Hooper D.C. NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agents Chemother 2006, 50:1104-1107.
28. Huang J., O'Toole P.W., Shen W., Amrine-Madsen H., Jiang X., Lobo N., et al. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob Agents Chemother 2004, 48:909-917.
29. Yamada Y., Hideka K., Shiota S., Kuroda T., Tsuchiya T. Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus. Biol Pharm Bull 2006, 29:554-556.
30. Narui K., Noguchi N., Wakasugi K., Sasatsu M. Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus. Biol Pharm Bull 2002, 25:1533-1536.
31. DeMarco C.E., Cushing L.A., Frempong-Manso E., Seo S.M., Jaravaza T.A., Kaatz G.W. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51:3235-3239.
32. Paulsen I.T., Brown M.H., Littlejohn T.G., Mitchell B.A., Skurray R.A. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci USA 1996, 93:3630-3635.
33. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., et al. Current protocols in molecular biology 2005, John Wiley and Sons, Inc., New York, NY.
34. Condon C. RNA processing and degradation in Bacillus subtilis. Microbiol Mol Biol Rev 2003, 67:157-174.
35. Kaberdin V.R., Blasi U. Translation initiation and the fate of bacterial mRNAs. FEMS Microbiol Rev 2006, 30:967-979.
36. Fournier B., Truong-Bolduc Q.C., Zhang X., Hooper D.C. A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J Bacteriol 2001, 183:2367-2371.
37. Kaatz G.W., Seo S.M. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 1997, 41:2733-2737.
38. Messina C., Cafiso V., Campanile F., Santagati M., Stefani S. Rapid method for detection of gyrA and grlA mutations in unrelated strains of staphylococci susceptible and resistant to levofloxacin. New Microbiol 2001, 24:347-353.
39. Kumaraswami M., Schuman J.T., Seo S.M., Kaatz G.W., Brennan R.G. Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepA. Nucleic Acids Res 2009, 37:1211-1224.
40. Truong-Bolduc Q.C., Ding Y., Hooper D.C. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus. J Bacteriol 2008, 190:7375-7381.
41. Truong-Bolduc Q.C., Hooper D.C. The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and β-lactams in Staphylococcus aureus. J Bacteriol 2007, 189:2996-3005.
42. Wang T., Tanaka M., Sato K. Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob Agents Chemother 1998, 42:236-240.
43. Mitchell B.A., Paulsen I.T., Brown M.H., Skurray R.A. Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J Biol Chem 1999, 274:3541-3548.
44. Hassan K.A., Skurray R.A., Brown M.H. Active export proteins mediating drug resistance in staphylococci. J Mol Microbiol Biotechnol 2007, 12:180-196.
45. Anderson K.L., Dunman P.M. Messenger RNA turnover processes in Escherichia coli, Bacillus subtilis, and emerging studies in Staphylococcus aureus. Int J Microbiol 2009, 2009:525491.
46. Pichon C., Felden B. Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains. Proc Natl Acad Sci USA 2005, 102:14249-14254.
47. Mahillon J., Chandler M. Insertion sequences. Microbiol Mol Biol Rev 1998, 62:725-774.
48. Berg D.E., Howe M.M. Mobile DNA 1989, ASM Press, Washington, DC.